We are live on ! Find out more
ABEO icon

Abeona Therapeutics

83 hedge funds and large institutions have $126M invested in Abeona Therapeutics in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 22

35% more capital invested

Capital invested by funds: $93.4M → $126M (+$33.1M)

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 8083 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.05% less ownership

Funds ownership: 2.13%2.08% (-0.05%)

13% less call options, than puts

Call options by funds: $198K | Put options by funds: $227K

Holders
83
Holders Change
+3
Holders Change %
+3.75%
% of All Funds
1.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
34
Reduced
22
Closed
9
Calls
$198K
Puts
$227K
Net Calls
-$29K
Net Calls Change
-$48K

ABEO Hedge Fund Activity: Q2 2020 in Review

83 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2020, worth a combined $126M — up 35% from $93.4M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ABEO positions and 9 closed out — a net gain of 3 holders — while 34 added to existing stakes and 22 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.73M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $3.06M sold.

  • 83 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2020, up from 80 in Q1 2020.
  • Funds reported $126M of Abeona Therapeutics stock for Q2 2020, up 35% quarter-over-quarter.
  • 12 funds opened new Abeona Therapeutics positions in Q2 2020 and 9 closed out, a net change of +3 holders.
  • The largest Abeona Therapeutics buyer in Q2 2020 was Millennium Management, an estimated $1.73M added.
  • The largest Abeona Therapeutics seller in Q2 2020 was Perceptive Advisors, an estimated $3.06M sold.

Based on aggregated 13F filings for Q2 2020.